- Home
- NAGE vs HRTX Comparison
NAGE vs HRTX Comparison
Compare NAGE & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | HRTX |
|---|---|---|
| Founded | 1999 | 1983 |
| Country | United States | United States |
| Employees | 117 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.2M | 228.3M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NAGE | HRTX |
|---|---|---|
| Price | $3.36 | $0.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $16.00 | $4.50 |
| AVG Volume (30 Days) | 667.9K | ★ 4.7M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | $16.51 | $15.28 |
| Revenue Next Year | $14.58 | $20.29 |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $3.29 | $0.38 |
| 52 Week High | $14.66 | $2.30 |
Technical Indicators
Market Signals| Indicator | NAGE | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 30.44 |
| Support Level | $3.35 | $0.38 |
| Resistance Level | $4.04 | $1.30 |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 37.74 | 42.30 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.